Ascendis Pharma A/S
ASND
Classement en actions
#1448
Ascendis Pharma A/S is a biopharmaceutical enterprise dedicated to advancing... Ascendis Pharma A/S is a biopharmaceutical enterprise dedicated to advancing therapeutic solutions for critical medical conditions that currently lack effective treatments. Its commercialized offering is SKYTROFA, a therapy prescribed for individuals suffering from growth hormone deficiency (GHD). The company boasts a robust development pipeline, featuring several TransCon-branded candidates. These include TransCon Growth Hormone (hGH), which is being progressed for pediatric GHD patients in Japan and for adults with GHD. Also under development are TransCon parathyroid hormone for adults with hypoparathyroidism, and TransCon CNP, aimed at treating pediatric achondroplasia. Further expanding its innovative portfolio, Ascendis is also developing a TransCon toll-like receptor (TLR) 7/8 agonist for intratumoral administration, alongside TransCon IL-2 ß/g, designed for systemic delivery. Founded in 2006, this enterprise maintains its corporate headquarters in Hellerup, Denmark.
Prix de l'action
$238.30
Dernière synchronisation: 2026-10-21
Capitalisation boursière
$14.86B
Changement (1 jour)
1.69%
Changement (1 an)
17.56%
Pays
DK
Échange Ascendis Pharma A/S (ASND)
Catégorie
Healthcare
Historique du prix de l'action pour Ascendis Pharma A/S (ASND)
Prix de clôture le plus élevé : $228.08 le 2026-10-01
Prix de clôture le plus bas : $19.55 le 2015-01-01
Prix de clôture le plus bas : $19.55 le 2015-01-01
Historique du prix de l'action de Ascendis Pharma A/S de 2015 à 2026
Performance annuelle du prix de l'action
| Année | Performance |
|---|---|
| 2026 (TTM) | 11.08% |
| 2025 | 53.71% |
| 2024 | 15.66% |
| 2023 | -2.60% |
| 2022 | -12.93% |
| 2021 | -20.35% |
| 2020 | 42.79% |
| 2019 | 94.20% |
| 2018 | 63.66% |
| 2017 | 87.65% |
| 2016 | 15.96% |
| 2015 | 0.00% |
Prix de l'action pour des entreprises similaires ou concurrentes
| Entreprise | Prix de l'action | Variation 1a% | Pays |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $763.31 | 8.49% |
CH
|
